Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D00907 (
CET
)
159
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Comparative studies on immunogenicity for compounds (TNBS,
CET
and 4-AAP) and compound-protein conjugates (TNBS-OA,
CET
-OA and 4-AAP-OA) were undertaken by the assay systems of humoral reaction (HA) and cellular reaction (DTH) in rabbits. The immunogenicity of TNBS-OA was substantially different from either that of
CET
-OA or 4-AAP-OA in the assay system of DTH. That is, rabbits immunized with TNBS-OA plus
FCA
displayed positive DTH reactions to the eliciting antigen (TNBS), while such reactions were never recognized in the rabbits immunized with
CET
-OA plus
FCA
or 4-AAP-OA plus
FCA
to the eliciting antigen of
CET
or 4-AAP, respectively. The above negative reactions observed in both groups,
CET
-OA and 4-AAP-OA, can be explained by the ordinary interpretation that the specificity of cellular immunoreaction (DTH) is directed toward the binding part of hapten-protein conjugate. By contrast, TNBS, spread on the skin to evoke DTH, may react with epidermal proteins in vivo to form 2,4,6-trinitrophenyl (TNP)-coupled protein. Consequently, it was suggested that this TNP-coupled protein evoked the positive DTH reaction in the TNBS-OA group.
...
PMID:[Comparative studies on delayed type hypersensitivity of low-molecular compounds and compound-protein conjugates in rabbits]. 207 39